Lupin, Cost Plus Drug and COPD Foundation to expand access to medication for COPD patients
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Subscribe To Our Newsletter & Stay Updated